adMare
News
January 15 2026
adMare BioInnovations Launches Ocythera: A New Canadian Life Sciences Company Advancing Therapies for Rare Bone Diseases
January 13 2026
Thryv Therapeutics Launches Pivotal Wave II Phase 2/3 Study in Long QT Syndrome Type 2
January 12 2026
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
January 09 2026
Find Therapeutics Announces Series A Extension Financing and Appointment of Dr. Thierry Abribat as Executive Chairman of the Board
December 17 2025
Thryv Therapeutics Announces Positive Phase 1 Results of THRV-1268 in Obese Participants
December 16 2025
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors
December 11 2025
adMare BioInnovations Launches Cohort VIII of the Executive Institute to Strengthen Leadership Driving Canadian Life Sciences Company Growth
December 03 2025
Thryv Therapeutics Strengthens Senior Leadership Team with Appointment of Matt Killeen, PhD, as Chief Business Officer
November 27 2025
CASTL Expands National Biomanufacturing Training with BioInnovation Scientist (BIS) Program
November 24 2025
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
November 20 2025
Amy Rudolph, PhD, Joins Thryv Therapeutics’ Board of Directors to Support Portfolio Progression into Heart Failure
Newsletter
Stay up to date on the
latest adMare news
Vancouver Innovation Centre
2405 Wesbrook Mall
Vancouver, British Columbia, Canada
V6T 1Z3
T. 604.364.1220
Toronto Office
MaRS Centre Heritage Building
101 College Street, Suite 250
Toronto, Ontario, Canada
M5G 1L7
T. 416.673.8100
Montreal Innovation Centre
7171 Frederick-Banting
Montréal, Québec, Canada
H4S 1Z9
